Disruptive Materials Pharma
We develop selected drug products based on our proprietary drug delivery platform, the pharma-grade mesoporous magnesium carbonate (Pharma-MMC, further information available on the MMC Technology section).
By a clever combination of already approved active pharmaceutical ingredients (APIs) with Pharma-MMC platform, several unique opportunities to realize highly valuable therapeutically equivalent or improved drug products emerges.
Our goal is to maximize the potential of the Company by harnessing the potential of our continuously expanding pool of high-performing, safe and IP-protected drug products based on Pharma-MMC.
DISRUPTIVE PHARMA is a stand-alone company that previously was operating under the DISRUPTIVE MATERIALS umbrella.